Physician profile
Tia Evenson
NPI 1972100766
$1,884.14
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $249 · 2022: $237 · 2023: $1,398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,398.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $233.77 | 2021-2023 | Ozempic, Rybelsus, Tresiba |
| Astrazeneca Pharmaceuticals LP | $174.25 | 2021-2023 | Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.29 | 2022-2023 | Tradjenta, Jardiance, Synjardy |
| Amgen INC. | $146.79 | 2022-2023 | Repatha, Otezla, Evenity |
| Idorsia Pharmaceuticals US INC | $145.56 | 2022-2023 | Quviviq |
| Glaxosmithkline, LLC. | $143.31 | 2021-2023 | Shingrix, Arexvy, Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $139.82 | 2022-2023 | Xarelto |
| Pfizer INC. | $128.58 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $122.01 | 2023 | Gemtesa |
| Astellas Pharma US INC | $97.21 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $64.15 | 2021-2022 | |
| Radius Health, INC. | $51.47 | 2023 | Tymlos |
| Otsuka America Pharmaceutical, INC. | $38.77 | 2023 | Nuedexta |
| Abbvie INC. | $37.18 | 2021-2023 | |
| Antares Pharma, INC. | $31.46 | 2022-2023 | Nocdurna, Xyosted, Tlando |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $29.44 | 2021-2023 | Mounjaro |
| Esperion Therapeutics, INC. | $21.71 | 2023 | Nexletol |
| Amarin Pharma, INC. | $21.48 | 2021 | |
| Boston Scientific Corporation | $21.21 | 2023 | |
| Scilex Pharmaceuticals INC. | $20.93 | 2021 | |
| Ge Healthcare | $18.89 | 2023 | |
| Sanofi Pasteur INC. | $14.46 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.40 | 2023 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tia Evenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.